| Status | Topic selection |
| Technology type | Medicine |
| Decision | Not selected |
| Reason for decision | Not eligible for Health Technology Evaluation guidance |
| Further information | Following confirmation from NHS England that the existing policy available for glucarpidase will be reviewed and updated once marketing authorisation (MA) is received, decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology. |
| ID number | 10761 |
Project Team
| Project lead | Danielle Lees |
Email enquiries
- If you have any queries please email Topic.Selection@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 09 December 2022 | Topic selection. Status changed to allow selection decision to be updated |
| 02 September 2022 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
For further information on how we select topics for development, please see our page about topic selection